Cargando…

Correction to: The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma

Detalles Bibliográficos
Autores principales:	Fodi, Christina, Skardelly, Marco, Hempel, Johann-Martin, Hoffmann, Elgin, Castaneda, Salvador, Tabatabai, Ghazaleh, Honegger, Jürgen, Tatagiba, Marcos, Schittenhelm, Jens, Behling, Felix
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9349120/ https://www.ncbi.nlm.nih.gov/pubmed/35599271 http://dx.doi.org/10.1007/s10143-022-01817-0

Ejemplares similares

The immunohistochemical expression of SSTR2A is an independent prognostic factor in meningioma
por: Fodi, Christina, et al.
Publicado: (2021)

Differences in the expression of SSTR1–5 in meningiomas and its therapeutic potential
por: Behling, Felix, et al.
Publicado: (2021)

The prognostic role of the immunohistochemical expression of S100 in meningiomas
por: Behling, Felix, et al.
Publicado: (2022)

Increased proliferation is associated with CNS invasion in meningiomas
por: Behling, Felix, et al.
Publicado: (2021)

The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy
por: Behling, Felix, et al.
Publicado: (2020)

CNS Invasion in Meningioma—How the Intraoperative Assessment Can Improve the Prognostic Evaluation of Tumor Recurrence
por: Behling, Felix, et al.
Publicado: (2020)

H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort
por: Behling, Felix, et al.
Publicado: (2020)

High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
por: Behling, Felix, et al.
Publicado: (2018)

The Current Role of Peptide Receptor Radionuclide Therapy in Meningiomas
por: Fodi, Christina-Katharina, et al.
Publicado: (2022)

Loss of H3K27me3 in meningiomas: an independent marker for CNS WHO grade 2?
por: Behling, Felix, et al.
Publicado: (2023)

Retrospective analysis of recurrence patterns and clinical outcome of grade II meningiomas following postoperative radiotherapy
por: Hoffmann, Elgin, et al.
Publicado: (2021)

Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort
por: Gonçalves, Vítor Moura, et al.
Publicado: (2021)

Correction: Gonçalves et al. Macrophage and Lymphocyte Infiltration Is Associated with Volumetric Tumor Size but Not with Volumetric Growth in the Tübingen Schwannoma Cohort. Cancers 2021, 13, 466
por: Gonçalves, Vítor Moura, et al.
Publicado: (2023)

Integrative assessment of brain and bone invasion in meningioma patients
por: Zwirner, Kerstin, et al.
Publicado: (2019)

Brain Invasion in Meningioma—A Prognostic Potential Worth Exploring
por: Behling, Felix, et al.
Publicado: (2021)

COX2 expression is associated with proliferation and tumor extension in vestibular schwannoma but is not influenced by acetylsalicylic acid intake
por: Behling, Felix, et al.
Publicado: (2019)

ADC-Based Stratification of Molecular Glioma Subtypes Using High b-Value Diffusion-Weighted Imaging
por: Nuessle, Nils C., et al.
Publicado: (2021)

COX2 expression is associated with preoperative tumor volume but not with volumetric tumor growth in vestibular schwannoma
por: Behling, Felix, et al.
Publicado: (2021)

A Continuous Correlation Between Residual Tumor Volume and Survival Recommends Maximal Safe Resection in Glioblastoma Patients: A Nomogram for Clinical Decision Making and Reference for Non-Randomized Trials
por: Skardelly, Marco, et al.
Publicado: (2021)

Glioma-Specific Diffusion Signature in Diffusion Kurtosis Imaging
por: Hempel, Johann-Martin, et al.
Publicado: (2021)

Correction to: Association of dynamic susceptibility magnetic resonance imaging at initial tumor diagnosis with the prognosis of different molecular glioma subtypes
por: Brendle, Cornelia, et al.
Publicado: (2021)

Association of dynamic susceptibility magnetic resonance imaging at initial tumor diagnosis with the prognosis of different molecular glioma subtypes
por: Brendle, Cornelia, et al.
Publicado: (2020)

Transition of a vestibular schwannoma to a malignant peripheral nerve sheath tumor with loss of H3K27 trimethylation after radiosurgery—a case report and review of the literature
por: Behling, Felix, et al.
Publicado: (2021)

COMPREHENSIVE MULTIPLATFORM ANALYSIS OF CDKN2A ALTERATIONS IN MENINGIOMAS
por: Wang, Justin Z, et al.
Publicado: (2023)

Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors
por: Engelhardt, Sophie, et al.
Publicado: (2022)

Dynamic Susceptibility Perfusion Imaging for Differentiating Progressive Disease from Pseudoprogression in Diffuse Glioma Molecular Subtypes
por: Richter, Vivien, et al.
Publicado: (2021)

Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
por: Wang, Justin Z., et al.
Publicado: (2023)

Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas
por: Wang, Justin Z., et al.
Publicado: (2023)

Clinical Significance of Somatostatin Receptor (SSTR) 2 in Meningioma
por: Wu, Wei, et al.
Publicado: (2020)

Frequency of BRAF V600E mutations in 969 central nervous system neoplasms
por: Behling, Felix, et al.
Publicado: (2016)

ATRX immunostaining predicts IDH and H3F3A status in gliomas
por: Ebrahimi, Azadeh, et al.
Publicado: (2016)

Differences in intraoperative sampling during meningioma surgery regarding CNS invasion – Results of a survey on behalf of the EANS skull base section
por: Behling, Felix, et al.
Publicado: (2023)

Value of SSTR2A and Claudin - 1 in Differentiating Meningioma from Schwannoma and Hemangiopericytoma
por: Anis, Shady E., et al.
Publicado: (2018)

SSTR-2 as a potential tumour-specific marker for fluorescence-guided meningioma surgery
por: Dijkstra, B. M., et al.
Publicado: (2018)

Complete and Incomplete Resection for Progressive Glioblastoma Prolongs Post-Progression Survival
por: Behling, Felix, et al.
Publicado: (2022)

The Value of SSTR2 Receptor-Targeted PET/CT in Proton Irradiation of Grade I Meningioma
por: Pelak, Maciej J., et al.
Publicado: (2021)

Tissue metabolites in diffuse glioma and their modulations by IDH1 mutation, histology, and treatment
por: Trautwein, Christoph, et al.
Publicado: (2022)

mRNA expression of somatostatin receptor subtypes SSTR-2, SSTR-3, and SSTR-5 and its significance in pancreatic cancer
por: Shahbaz, Muhammad, et al.
Publicado: (2015)

The effect of strength and endurance training on SSTR2 and SSTR5 in patients with colorectal cancer
por: Zanjani, Farhad Safari, et al.
Publicado: (2019)

GLINT: GlucoCEST in neoplastic tumors at 3 T—clinical results of GlucoCEST in gliomas
por: Bender, Benjamin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jj309d8gmegrl4mpm7m5raj4i4